Psoriasis
Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas
Joshua A. Zeichner, MD Mount Sinai Medical Center, New York, New York Disclosure: Dr. Zeichner is a consultant for Promius Pharma. Abstract Psoriasis in some body parts can be challenging to treat. Psoriasis in the scalp, palms and soles, and intertriginous areas differ from disease on other body parts, and treatment regimens must be tailored [...]
Drug-Provoked Psoriasis: Is It Drug Induced or Drug Aggravated? Understanding Pathophysiology and Clinical Relevance
Grace K. Kim, DO, Dermatology Research Fellow, Mohave Skin & Cancer Clinics, Las Vegas, Nevada; James Q. Del Rosso, DO, Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada, and Director of Dermatology Research, Mohave Skin & Cancer Clinics, Las Vegas, Nevada Abstract Psoriasis is a commonly encountered dermatosis with a variety of internal [...]
A Practical Approach to Screening Psoriasis Patients for Therapy with Biologic Agents
by Joshua A. Zeichner, MD Author: Dr. Zeichner is a Chief Resident, Department of Dermatology, Mount Sinai Medical Center, New York, New York. Section Editors: Jerry Tan, MD, FRCPC, is Adjunct Professor, University of Western Ontario, London, Ontario; President, Windsor Clinical Research Inc., Windsor, Ontario; and Consultant, Windsor Regional Hospital, Windsor, Ontario, Canada. He is [...]
fred klumpp |&co
Recent Comments